TITAN PHARMACEUTICALS INC — Director's Dealing 2012

Jan 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2012-01-03

Reporting Person: Cavalier Eurelio M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Option to Purchase Common Stock	$1.15	A	35000	Acquired	2022-01-03	Common Stock (35000)	Direct

Footnotes

F1: These options vest in 12 equal monthly installments beginning on the grant date.